Form 4 for IMNN Imunon, Inc.
Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-07 · accession 0001493152-23-044386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-11 | 2023-12-07 | IMNN | Hazard Sebastien | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2023-12-11 | 2023-12-07 | IMNN | Hazard Sebastien | Chief Medical Off | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-07 | A | A | 20,000 | $0.00 | 20,000 | D | — | — | (F1) Represents grant of restricted stock, which vests on December 11, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-12-07 | A | A | 80,000 | $0.00 | 80,000 | D | $0.88 · — to 2033-12-11 | 80,000 Common Stock | (F2) Represents grant of stock option, which vests with respect to 25% of the shares on December 11, 2024, and the remaining 75% in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of December 11, 2023. |